We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-13.27%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$18.6B
AUM Growth
-$3.22B
Cap. Flow
-$14.7M
Cap. Flow %
-0.08%
Top 10 Hldgs %
18.18%
Holding
3,301
New
145
Increased
1,425
Reduced
1,371
Closed
260

Sector Composition

Rank Sector Weight
1 Technology 9.03%
2 Financials 4.72%
3 Healthcare 4.25%
4 Consumer Discretionary 4.16%
5 Industrials 2.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHF
2951
BNY Mellon High Yield Strategies Fund
DHF
$176M
$41K ﹤0.01%
18,277
+2,324
+15% +$5.77K
LMDX
2952
DELISTED
LumiraDx Limited Common Shares
LMDX
$40K ﹤0.01%
+14,902
New +$59.7K
VORB
2953
DELISTED
Virgin Orbit Holdings, Inc. Common Stock
VORB
$40K ﹤0.01%
10,500
+100
+1% +$496
HOFV
2954
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$39K ﹤0.01%
2,987
+136
+5% +$2.27K
OCGN icon
2955
Ocugen
OCGN
$458M
$39K ﹤0.01%
17,036
+1,000
+6% +$2.39K
OTLY
2956
Oatly Group
OTLY
$441M
$39K ﹤0.01%
559
+8
+1% +$624
TGB
2957
Trekor Metals
TGB
$3.08B
$39K ﹤0.01%
36,450
ANNX icon
2958
Annexon
ANNX
$862M
$38K ﹤0.01%
+10,000
New +$30.6K
CLSD
2959
DELISTED
Clearside Biomedical
CLSD
$38K ﹤0.01%
1,733
CIFR icon
2960
Cipher Digital
CIFR
$6.9B
$37K ﹤0.01%
26,750
BMTX.WS
2961
DELISTED
BM Technologies, Inc. Warrants, each warrant exercisable for one share of Common Stock at an exercise price of $11.50
BMTX.WS
$36K ﹤0.01%
73,400
+15,000
+26% +$12.9K
AIM
2962
AIM ImmunoTech
AIM
$7.17M
$36K ﹤0.01%
467
GNSS icon
2963
Genasys
GNSS
$77.9M
$34K ﹤0.01%
+10,410
New +$33.4K
REI icon
2964
Ring Energy
REI
$349M
$34K ﹤0.01%
12,800
-4,000
-24% -$16.6K
ISUN
2965
DELISTED
iSun, Inc. Common Stock
ISUN
$34K ﹤0.01%
10,370
LFMD icon
2966
LifeMD
LFMD
$167M
$33K ﹤0.01%
16,204
+1,204
+8% +$2.99K
IMDX
2967
Insight Molecular Diagnostics
IMDX
$121M
$33K ﹤0.01%
1,825
-30
-2% -$682
SAN icon
2968
Banco Santander
SAN
$211B
$33K ﹤0.01%
11,746
-402
-3% -$1.23K
VKTX icon
2969
Viking Therapeutics
VKTX
$3.84B
$33K ﹤0.01%
11,313
DMK
2970
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$32K ﹤0.01%
919
HYZN
2971
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$31K ﹤0.01%
213
-833
-80% -$176K
WPRT
2972
Westport Fuel Systems
WPRT
$32.7M
$30K ﹤0.01%
3,005
-34
-1% -$421
RNXT icon
2973
RenovoRx
RNXT
$56.8M
$29K ﹤0.01%
14,400
BDTX icon
2974
Black Diamond Therapeutics
BDTX
$116M
$28K ﹤0.01%
11,231
GOEV
2975
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$28K ﹤0.01%
33
-1
-3% -$1.76K

Similar funds

Cambridge Investment Research Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Cambridge Investment Research Advisors held 3,301 positions worth $18.6B, down 15% from $21.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors's Q2 2022 filing shows 145 new, 1,425 increased, 1,371 reduced and 260 closed positions. Its largest new stake was Simplify US Equity PLUS Downside Convexity ETF: 863,983 shares worth $22.9M. The largest sale was Invesco QQQ Trust, an estimated $84.3M.

By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.9% a quarter earlier, followed by Financials and Healthcare.

  • Cambridge Investment Research Advisors's largest Q2 2022 buy was Simplify US Equity PLUS Downside Convexity ETF: 863,983 shares worth $22.9M.
  • Cambridge Investment Research Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q2 2022, an estimated $82M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2022 reduction was Invesco QQQ Trust, cutting an estimated $84.3M.
  • Cambridge Investment Research Advisors fully exited State Street SPDR Bloomberg International Treasury Bond ETF in Q2 2022, selling an estimated $18M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $18.6B portfolio in Q2 2022.
  • Cambridge Investment Research Advisors opened 145 new positions and closed 260 in Q2 2022.
  • Cambridge Investment Research Advisors's portfolio value fell 15% quarter-over-quarter to $18.6B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2022, filed 13 Jul 2022.